Yarrow Bioscience publishes investor presentation; VYNE makes available on website

VYNE Therapeutics Inc.

Yarrow Bioscience published an investor presentation dated July 14, 2026, which VYNE made available on its website.
The presentation is related to the proposed transaction between VYNE and Yarrow, as referenced in the S-4 registration statement.
No specific financial or operational details from the presentation are included in the filing text provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.